Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: BulbaMan who wrote (1939)	11/6/2000 9:53:10 AM
From: Biomaven	Read Replies (4) \| Respond to of 52153

BulbaMan, By the way, PPGx, (the company mentioned in Fortune) is private but its majority owner, AXPH, is publicly traded and seems undervalued to me These sort of observations are often well worth pursuing, although sometimes they are frustratingly slow to have an impact on the parent company valuation. Rick has pointed to at least NBSC (with its DGI sub) and BTRN (with its stem cell sub) as examples. CEGE and its ABGX holding have often been mentioned on this thread. Connetics' holding in ITMN has suddenly become much more significant with the collapse of the CNCT stock price. Any other situations like this that people care to point to? Peter